Thus, despite tau pathology being at the very core of all non-AD tauopathies, these disorders are limited to markers of global neurodegeneration (e.g., neurofilament light) [34] as no disease-specific biomarkers are currently available. This evidence concerns the gene MAPT and Alzheimer disease.